Paralysed man can feel objects through another person's hand Keith Thomas, a man in his 40s with no sensation or movement in his hands, is able to feel and move objects by controlling another person's hand via a brain implant. The technique might one day even allow us to experience another person's body over long distances. Keith Thomas (right) was able to control another person's hand A man with paralysis has been able to move and sense another person's hand as if it were his own, thanks to a new kind of "telepathic" brain implant. "We created a mind-body connection between two different individuals," says Chad Bouton at the Feinstein Institutes for Medical Research in New York state. The approach could be used as a form of rehabilitation after spinal cord injury, allowing people with paralysis to work together, and may one day even allow people to share experiences remotely, says Bouton.

"Fargo" series creator Noah Hawley spoke with Fox News Digital at the Emmys, and warned that while he doesn't think AI can replicate human creativity, it still poses a threat. Noah Hawley attends the premiere of FOX's "Lucy In The Sky" at Darryl Zanuck Theater at FOX Studios on Sept. 25, 2019, in Los Angeles. READY FOR BATTLE: "Fargo" series creator Noah Hawley is wary of the good and bad in artificial intelligence. AI OPTIMISM: A prominent Silicon Valley businessman and venture capitalist believes artificial intelligence can spur deflation and create enough growth to help those whose jobs will be lost to the technology. MEDICAL MIRACLE: A New York man who was left paralyzed after a diving accident is starting to regain movement a year after receiving an artificial intelligence-powered implant in his brain.

A New York man who was left paralyzed after a diving accident is starting to regain movement a year after receiving an artificial intelligence-powered implant in his brain. A year ago, Keith Thomas, 46, was only able to move his arms an inch. Today, after the groundbreaking procedure, he is able to extend his arm, grasp a cup and take a drink using only his thoughts and stimulation. He has also regained more sensation in his wrist and arm, allowing him to feel the fur of his family's dog. In 2020, Thomas was living on Long Island and working as a trader on Wall Street when he experienced a diving accident that left him paralyzed from the chest down.

The Feinstein Institutes for Medical Research has spun out a startup whose artificial-intelligence device could help paralyzed patients regain the use of their hands. Earlier this month, the startup, Neuvotion Inc., announced a $1.1 million funding round from the Long Island Angel Network and the Good Shepherd Rehabilitation Network based in Allentown, Pennsylvania. The Darien, Connecticut, startup is in the process of transferring research developed in the laboratory of Chad Bouton, vice president of advanced engineering at the Feinstein Institutes, a unit of Northwell Health. Bouton also is founder of Neuvotion. The company's initial device, NeuStim, is worn as a patch on the patient's forearm and is being positioned for use in clinics and at home.

Some studies suggest it can boost memory function in the brain, increase your energy, keep your immune system strong and even help maintain healthy glowing skin. One study found that patients get their vital signs collected every four hours, during the day and night--not the best environment for a restful night of sleep. But researchers at The Feinstein Institutes for Medical Research are hoping to change that routine by using a new artificial intelligence (AI) tool that is intended to predict which patients don't need to be woken up for vital monitoring. "The goal of monitoring vital signs is to best care for the patients and to intervene therapeutically to rescue patients if and when their vital signs become unstable," Jamie Hirsch, MD, director, Data Science and Predictive Analytics at Northwell Health and co-senior author of the Feinstein study, tells Verywell. "But the frequency of monitoring is also a result of habit and culture. There is no evidence-based standard dictating how frequently patients need to be monitored."

The Feinstein Institutes for Medical Research, a division of the Northwell Health system, has developed an artificial intelligence tool to gauge when hospitalized patients need to be woken up during the night. By letting patients sleep, the health system can speed up patients' recovery and discharge them faster. It can also help avoid causing delirium in patients, noted Theodoros Zanos, Ph.D., assistant professor at the Feinstein Institutes' Institute of Bioelectronic Medicine. "It actually is a critical piece of a person getting better in the hospital," Zanos told Fierce Healthcare. "We know that sleep disruption can essentially slow down recovery."

A team from Feinstein Institutes for Research thinks AI could be key to helping patients get more rest while reducing the burden on healthcare staff. Everyone knows how important adequate sleep is for recovery. However, patients in pain – or just insomniacs like me – can struggle to get the sleep they need. "Rest is a critical element to a patient's care, and it has been well-documented that disrupted sleep is a common complaint that could delay discharge and recovery," said Theodoros Zanos, Assistant Professor at Feinstein Institutes' Institute of Bioelectronic Medicine. When a patient finally gets some shut-eye, the last thing they want is to be woken up to have their vitals checked--but such measurements are, well, vital.

Vital sign (VS) monitoring disruptions for hospitalized patients during overnight hours have been linked to cognitive impairment, hypertension, increased stress and even mortality. For the first time, a team at The Feinstein Institutes for Medical Research developed a deep-learning predictive clinical tool to identify which patients do not need to be woken up overnight – allowing them to rest, recover and discharge faster. The study's results, based on 24.3 million vital sign measurements, were published today in Nature Partner Journals Digital Medicine. A team, led by Theodoros Zanos, PhD, in close collaboration with Jamie Hirsch, MD, collected and analyzed data from multiple Northwell Health hospitals between 2012 and 2019, which consisted of 2.13 million patient visits. They used this vast body of clinical data from the patient visits – respiratory rate, heart rate, systolic blood pressure, body temperature, patient age, etc. – to develop an algorithm that predicts a hospitalized patient's overnight stability, and if they could be left uninterrupted overnight to sleep.

A gene therapy treatment for Parkinson's disease appears to relieve symptoms by rewiring the brain circuits involved in movement. People with Parkinson's disease have tremors and muscle stiffness that are caused by overstimulation of a brain area called the subthalamic nucleus, which is responsible for coordinating the brain's motor regions. In a trial published in 2011, researchers at the Feinstein Institute for Medical Research in New York found that a gene therapy designed to turn down the activity of the subthalamic nucleus improved motor control for people with Parkinson's. Though the treatment reduced Parkinson's symptoms for at least a year, it was unclear how. To find out, the researchers have since used PET scans to compare the brains of 15 people who received the gene therapy with 20 who received a placebo.